Indication

Non-infectious intermediate uveitis

1 clinical trial

1 product

Clinical trial

A Phase 2 Randomized, Double-Masked, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active Non-Infectious Intermediate-, Posterior-, and Panuveitis

Status: Active (not recruiting), Estimated PCD: 2024-07-01

Product